Grifols SA (GIFLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved Cash ... [Yahoo! Finance]
GRIFOLS SA S/ADR (GIKLY)
NASDAQ:AMEX Investor Relations:
grifols.com/en/web/international/investor-relations/home-page
Company Research
Source: Yahoo! Finance
Adjusted EBITDA: EUR 462 million for Q3 with a margin of nearly 26%, a 26.7% improvement at constant currency from the previous year. Free Cash Flow: Improved to EUR 127 million in Q3. Leverage Ratio: Reduced to 5.1 from 6.8 in Q1. BioPharma Growth: 12.1% increase in Q3 and 9.1% year-to-date on a constant currency basis. IG Franchise Growth: 16.6% increase in Q3 and 14.3% year-to-date on a constant currency basis. Subcutaneous IG Growth: 52% increase year-to-date on a constant currency basis. Albumin Growth: 11.7% increase in Q3 and 10.3% year-to-date on a constant currency basis. Diagnostics Growth: 1.3% increase in Q3 on a constant currency basis, 1.7% year-to-date. Gross Profit: Up 14.5% year-to-date versus 2023. Net Income: Positive EUR 88 million year-to-date, reversing a negative position in 2023. CapEx: Expected to be around EUR 280 million for 2024, primarily related to ImmunoTek. Liquidity: Stood at EUR 704 million at the end of Q3. Warning! GuruFocus
Show less
Read more
Impact Snapshot
Event Time:
GIKLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GIKLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GIKLY alerts
High impacting GRIFOLS SA S/ADR news events
Weekly update
A roundup of the hottest topics
GIKLY
News
- Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8% [Yahoo! Finance]Yahoo! Finance
- Grifols Signals It Would Reject $6.8 Billion Brookfield Bid [BNN Bloomberg (Canada)]BNN Bloomberg
- Grifols Board Issues Unfavorable Opinion on Brookfield Offer [Yahoo! Finance]Yahoo! Finance
- Grifols: Brookfields potential $6.8 billion offer undervalues the firm [Yahoo! Finance Canada]Yahoo! Finance Canada
- Brookfield Weighs €6.45 Billion Bid for Grifols; Shares Drop [BNN Bloomberg (Canada)]BNN Bloomberg